Go Pro
→ Major Buy Alert Issued for September 30th (From TradeSmith) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HSM
Helius Medical Technologies
C$0.00
C$14.26
▼
C$40.00
C$42.54MN/A3,578 shs930 shs
PulteGroup, Inc. stock logo
PHM
PulteGroup
$124.68
+0.3%		$128.73
$108.49
▼
$144.49
$23.30B1.191.22 million shs922,396 shs
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
$82.21
+0.2%		$83.37
$81.17
▼
$92.18
$41.41B0.5131.94 million shs16.51 million shs
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
C$0.10
+5.6%		C$0.10
C$0.08
▼
C$0.19
C$18.32M-0.788135121,430 shs111,622 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HSM
Helius Medical Technologies
0.00%0.00%0.00%0.00%0.00%
PulteGroup, Inc. stock logo
PHM
PulteGroup
+0.42%-2.08%-5.72%+4.76%-6.87%
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
+0.15%-1.28%-0.91%-3.52%-5.20%
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
0.00%-10.00%-14.29%-30.77%-18.18%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HSM
Helius Medical Technologies
C$0.00
C$14.26
▼
C$40.00
C$42.54MN/A3,578 shs930 shs
PulteGroup, Inc. stock logo
PHM
PulteGroup
$124.68
+0.3%		$128.73
$108.49
▼
$144.49
$23.30B1.191.22 million shs922,396 shs
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
$82.21
+0.2%		$83.37
$81.17
▼
$92.18
$41.41B0.5131.94 million shs16.51 million shs
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
C$0.10
+5.6%		C$0.10
C$0.08
▼
C$0.19
C$18.32M-0.788135121,430 shs111,622 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HSM
Helius Medical Technologies
0.00%0.00%0.00%0.00%0.00%
PulteGroup, Inc. stock logo
PHM
PulteGroup
+0.42%-2.08%-5.72%+4.76%-6.87%
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
+0.15%-1.28%-0.91%-3.52%-5.20%
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
0.00%-10.00%-14.29%-30.77%-18.18%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HSM
Helius Medical Technologies
0.00
N/AN/AN/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
2.72
Moderate Buy$142.2014.05% Upside
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
0.00
N/AN/AN/A
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TLT, PHM, VPT, and HSM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/24/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetPeer Perform ➝ Outperform$129.00
8/24/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$158.00
8/21/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
8/18/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
7/24/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$138.00 ➝ $134.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$166.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$115.00 ➝ $116.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$162.00
7/23/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$123.00 ➝ $124.00
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HSM
Helius Medical Technologies
C$477K0.00N/A5.71C$3.61 per share0.00
PulteGroup, Inc. stock logo
PHM
PulteGroup
$17.31B1.35$12.70 per share9.82$69.42 per share1.80
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/AN/AN/AN/AN/AN/A
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
C$179.93K101.84C$0.02 per share5.53C($0.02) per share-3.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HSM
Helius Medical Technologies
N/A-C$11.02N/AN/AN/AN/AN/AN/AN/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
$2.22B$9.7912.7411.221.5311.62%15.21%10.89%10/22/2026 (Estimated)
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
-C$5.25M-C$0.02N/AN/AN/A-1,778.62%78.25%-136.72%N/A

Latest TLT, PHM, VPT, and HSM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2026Q2 2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
$2.36$2.48+$0.12$2.48$3.94 billion$3.98 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HSM
Helius Medical Technologies
N/AN/AN/AN/AN/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
$1.040.83%+12.97%10.62%7 Years
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
$4.215.12%N/AN/AN/A
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
N/AN/AN/AN/AN/A

Latest TLT, PHM, VPT, and HSM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/2/2026
PulteGroup, Inc. stock logo
PHM
PulteGroup
quarterly$0.260.84%9/15/20269/15/202610/2/2026
8/31/2026
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
monthly$0.31474.61%9/1/20269/1/20269/4/2026
7/31/2026
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
monthly$0.33054.82%8/3/20268/3/20268/6/2026
6/30/2026
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
Monthly$0.31804.46%7/1/20267/1/20267/7/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HSM
Helius Medical Technologies
0.74
4.20
3.58
PulteGroup, Inc. stock logo
PHM
PulteGroup
0.14
0.78
0.78
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/AN/AN/A
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
-63.20
0.08
6.67

Institutional Ownership

CompanyInstitutional Ownership
HSM
Helius Medical Technologies
N/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
89.90%
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
73.33%
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
4.06%

Insider Ownership

CompanyInsider Ownership
HSM
Helius Medical Technologies
N/A
PulteGroup, Inc. stock logo
PHM
PulteGroup
0.75%
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/A
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
2.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
HSM
Helius Medical Technologies
192.32 millionN/ANot Optionable
PulteGroup, Inc. stock logo
PHM
PulteGroup
6,506187.45 million186.05 millionOptionable
iShares 20+ Year Treasury Bond ETF stock logo
TLT
iShares 20+ Year Treasury Bond ETF
N/A503.70 millionN/AOptionable
VentriPoint Diagnostics Ltd. stock logo
VPT
VentriPoint Diagnostics
147,000192.88 millionN/ANot Optionable

Recent News About These Companies

UniDoc Health Corp.: UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform
August 20, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69364214-unidoc-health-corp-unidoc-health-signs-mou-with-ventripoint-diagnostics-to-evaluate-remote-cardiac-assessment-and-screening-platform-200.htm
UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform
August 20, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/VPT-X/pressreleases/3947715/unidoc-health-signs-mou-with-ventripoint-diagnostics-to-evaluate-remote-cardiac-assessment-and-screening-platform/
Ventripoint broadens access to AI cardiac imaging
August 13, 2026  |  msn.comhttps://www.msn.com/en-ca/technology/tech-companies/ventripoint-broadens-access-to-ai-cardiac-imaging/ar-AA2a0OGV
Stocks in play: Ventripoint Diagnostics Ltd
August 12, 2026  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/news/stocks-play-ventripoint-diagnostics-ltd-140600412.html
Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living With Heart Disease
June 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ventripoint-ollie-hinkle-heart-foundation-124539096.html
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
June 17, 2026  |  newswire.cahttps://www.newswire.ca/news-releases/16-million-people-one-underserved-disease-the-ai-imaging-push-to-close-the-congenital-heart-gap-800276810.html
Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
May 19, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/05/19/10385296.htm
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
May 13, 2026  |  financialpost.comF
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
May 13, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/a-toronto-ai-cardiac-diagnostics-company-just-cleared-three-of-the-hardest-validation-bars-in-medtech-1036149892
The $59B Quiet Shift Reshaping How Patients Access Care
May 12, 2026  |  newswire.cahttps://www.newswire.ca/news-releases/the-59b-quiet-shift-reshaping-how-patients-access-care-840510414.html
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money
May 12, 2026  |  newswire.cahttps://www.newswire.ca/news-releases/wall-street-s-cardiac-bet-where-diagnostics-meet-the-money-858207617.html
Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
May 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/ventripoint-exhibit-59th-annual-meeting-132316747.html
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
April 29, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/04/29/10373873.htm
The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
April 29, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/04/29/10373720.htm
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
April 16, 2026  |  financialpost.comF
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026  |  financialpost.comF
VentriPoint Diagnostics Ltd.
April 8, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/vpt/financials?countrycode=ca
The Hidden Crisis Driving Billions into Cardiac Care Innovation
March 27, 2026  |  baystreet.cahttps://www.baystreet.ca/stockstowatch/22996/The-Hidden-Crisis-Driving-Billions-into-Cardiac-Care-Innovation
Ventripoint Taps LG Consulting to Drive VMS+ Rollout in Northern California
March 13, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/560731/ventripoint-taps-lg-consulting-to-drive-vms-rollout-in-northern-california/
(CNW) Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
March 4, 2026  |  marketwatch.comhttps://www.marketwatch.com/press-release/cnw-hospital-networks-turn-to-ai-enhanced-cardiac-imaging-to-cut-costs-and-improve-outcomes-49b31ea8

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
NVIDIA logo displayed on a computer chip surrounded by illuminated green circuit board traces.
NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
By Thomas Hughes | August 11, 2026
Computer monitor on a desk displaying a candlestick stock price chart showing a decline followed by an upward rebound.
3 Contrarian Trades for a Market That Looks Too Hot
By Bridget Bennett | August 25, 2026
Illustration of an upward-trending candlestick stock chart and rising bar graph overlaid on a blurred city skyline at night.
These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
By Nathan Reiff | August 29, 2026

Helius Medical Technologies TSE:HSM

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

PulteGroup stock logo

PulteGroup NYSE:PHM

$124.68 +0.37 (+0.30%)
As of 03:58 PM Eastern

PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States. It acquires and develops land primarily for residential purposes; and constructs housing on such land. The company also offers various home designs, including single-family detached, townhomes, condominiums, and duplexes under the Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West brand names. In addition, the company arranges financing through the origination of mortgage loans primarily for homebuyers; sells the servicing rights for the originated loans; and provides title insurance policies, and examination and closing services to homebuyers. PulteGroup, Inc. was founded in 1950 and is headquartered in Atlanta, Georgia.

iShares 20+ Year Treasury Bond ETF stock logo

iShares 20+ Year Treasury Bond ETF NASDAQ:TLT

$82.21 +0.14 (+0.17%)
As of 04:00 PM Eastern

iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years. The Underlying Index includes all publicly-issued the United States Treasury securities that have a remaining maturity of greater than or equal to 20 years. BlackRock Fund Advisors serves as investment adviser of the Fund.

VentriPoint Diagnostics stock logo

VentriPoint Diagnostics CVE:VPT

C$0.10 +0.01 (+5.56%)
As of 03:49 PM Eastern

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas